GCM
CVAC

Ghisallo Capital Management’s CureVac CVAC Stock Holding History

Ghisallo Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-100,000
Closed -$1.04M – 129
2023
Q2 		$1.04M Hold
100,000
– – 0.12% 93
2023
Q1 		$697K Buy
+100,000
New +$872K 0.17% 51

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Ghisallo Capital Management's CVAC Position: Q3 2023 in Review

Ghisallo Capital Management sold out of CureVac (CVAC) in Q3 2023, closing a stake of 100,000 shares — an estimated $1.04M sold.

Ghisallo Capital Management first reported a position in CVAC in Q1 2023 and held it in 2 quarters. The position peaked at $1.04M in Q2 2023. 84 funds tracked by Wall St. Rank hold CVAC as of Q3 2023.

  • Ghisallo Capital Management reported no remaining CureVac position as of Q3 2023 after selling out during the quarter.
  • Ghisallo Capital Management sold 100,000 CureVac shares in Q3 2023, an estimated $1.04M.
  • Ghisallo Capital Management first reported a position in CureVac in Q1 2023 and held it in 2 quarters.
  • Ghisallo Capital Management's CureVac position peaked at $1.04M in Q2 2023.
  • 84 funds tracked by Wall St. Rank held CureVac as of Q3 2023.

Based on Ghisallo Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.